New York State Common Retirement Fund’s PTC Therapeutics PTCT Stock Holding History

New York State Common Retirement Fund’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13M	Buy	38,427 +9,512	+33%	+$687K	﹤0.01%	1280
2026 Q1	$1.97M	Hold	28,915	–	–	﹤0.01%	1392
2025 Q4	$2.2M	Sell	28,915 -1,601	-5%	-$116K	﹤0.01%	1362
2025 Q3	$1.87M	Buy	30,516 +5,095	+20%	+$265K	﹤0.01%	1464
2025 Q2	$1.24M	Hold	25,421	–	–	﹤0.01%	1590
2025 Q1	$1.3M	Buy	25,421 +2,000	+9%	+$99.8K	﹤0.01%	1540
2024 Q4	$1.06M	Hold	23,421	–	–	﹤0.01%	1660
2024 Q3	$869K	Sell	23,421 -10,000	-30%	-$335K	﹤0.01%	1733
2024 Q2	$1.02M	Sell	33,421 -15,563	-32%	-$504K	﹤0.01%	1750
2024 Q1	$1.42M	Sell	48,984 -7,999	-14%	-$224K	﹤0.01%	1604
2023 Q4	$1.57M	Sell	56,983 -16,864	-23%	-$386K	﹤0.01%	1571
2023 Q3	$1.65M	Buy	73,847 +10,223	+16%	+$380K	﹤0.01%	1523
2023 Q2	$2.59M	Sell	63,624 -7,060	-10%	-$345K	﹤0.01%	1401
2023 Q1	$3.42M	Sell	70,684 -5,775	-8%	-$264K	﹤0.01%	1322
2022 Q4	$2.92M	Sell	76,459 -2,927	-4%	-$122K	﹤0.01%	1443
2022 Q3	$3.98M	Buy	79,386 +5,690	+8%	+$279K	0.01%	1274
2022 Q2	$2.95M	Buy	73,696 +10,043	+16%	+$352K	﹤0.01%	1464
2022 Q1	$2.38M	Buy	63,653 +787	+1%	+$30.3K	﹤0.01%	1650
2021 Q4	$2.5M	Sell	62,866 -18,319	-23%	-$701K	﹤0.01%	1657
2021 Q3	$3.02M	Sell	81,185 -6,639	-8%	-$273K	﹤0.01%	1530
2021 Q2	$3.71M	Buy	87,824 +32,024	+57%	+$1.37M	﹤0.01%	1488
2021 Q1	$2.64M	Hold	55,800	–	–	﹤0.01%	1616
2020 Q4	$3.4M	Sell	55,800 -1,600	-3%	-$94.3K	﹤0.01%	1414
2020 Q3	$2.68M	Hold	57,400	–	–	﹤0.01%	1428
2020 Q2	$2.91M	Buy	57,400 +1,900	+3%	+$93.4K	﹤0.01%	1372
2020 Q1	$2.48M	Hold	55,500	–	–	﹤0.01%	1329
2019 Q4	$2.67M	Sell	55,500 -5,500	-9%	-$234K	﹤0.01%	1489
2019 Q3	$2.06M	Buy	61,000 +2,300	+4%	+$100K	﹤0.01%	1632
2019 Q2	$2.64M	Buy	58,700 +13,000	+28%	+$513K	﹤0.01%	1518
2019 Q1	$1.72M	Hold	45,700	–	–	﹤0.01%	1688
2018 Q4	$1.57M	Sell	45,700 -4,700	-9%	-$169K	﹤0.01%	1676
2018 Q3	$2.37M	Hold	50,400	–	–	﹤0.01%	1588
2018 Q2	$1.7M	Buy	50,400 +4,500	+10%	+$140K	﹤0.01%	1789
2018 Q1	$1.24M	Buy	45,900 +4,100	+10%	+$104K	﹤0.01%	1891
2017 Q4	$697K	Sell	41,800 -10,972	-21%	-$186K	﹤0.01%	2213
2017 Q3	$1.06M	Buy	52,772 +2,122	+4%	+$41.5K	﹤0.01%	1976
2017 Q2	$928K	Buy	50,650 +18,249	+56%	+$246K	﹤0.01%	2085
2017 Q1	$319K	Buy	32,401 +1	+0%	+$12	﹤0.01%	2595
2016 Q4	$353K	Hold	32,400	–	–	﹤0.01%	2530
2016 Q3	$454K	Hold	32,400	–	–	﹤0.01%	2360
2016 Q2	$227K	Hold	32,400	–	–	﹤0.01%	2670
2016 Q1	$209K	Sell	32,400 -300	-0.9%	-$5.21K	﹤0.01%	2657
2015 Q4	$1.06M	Hold	32,700	–	–	﹤0.01%	1938
2015 Q3	$873K	Buy	32,700 +1,341	+4%	+$57.4K	﹤0.01%	2023
2015 Q2	$1.51M	Buy	+31,359	New	+$1.83M	﹤0.01%	1984

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

New York State Common Retirement Fund's PTCT Position: Q2 2026 in Review

New York State Common Retirement Fund increased its PTC Therapeutics (PTCT) stake by 33% in Q2 2026, buying an estimated $687K and bringing the position to 38,427 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

New York State Common Retirement Fund first reported a position in PTCT in Q2 2015 and has held it in 45 quarters since. The position peaked at $3.98M in Q3 2022. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

New York State Common Retirement Fund held 38,427 shares of PTC Therapeutics worth $3.13M as of Q2 2026.
New York State Common Retirement Fund bought 9,512 PTC Therapeutics shares in Q2 2026, an estimated $687K.
PTC Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1280 holding.
New York State Common Retirement Fund first reported a position in PTC Therapeutics in Q2 2015 and has held it in 45 quarters since.
New York State Common Retirement Fund's PTC Therapeutics position peaked at $3.98M in Q3 2022.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.